Karnataka Minister CT Ravi tests positive for COVID-19

Mangaluru, Jun 15: A 69-year-old man was murdered by his two sons at Muggaguthu in Karaya village under the limits of Uppinangady police station in Dakshina Kannada district. 

According to Police, accused Monappa Poojary (34) and Naveen (28) assaulted Dharnappa Poojary with sickle and wooden logs on Sunday night, leading to his on-the-spot death.

A family discord led to the murder, police said, adding that a case has been registered at Uppinangady police station and investigation was in progress.

Bengaluru, May 3: Five more COVID-19 cases have been reported from Karnataka, taking the total number of coronavirus cases in the state to 606, the state government said on Sunday.

The total number of cases includes, 25 deaths and 282 discharged.

"Five new COVID-19 positive cases have been reported in Karnataka from 2nd May, 5 pm to 3rd May, 12 noon; taking the total number of positive cases to 606 which includes 25 deaths and 282 discharges," the government stated.

According to the statement, out of the five cases, three have been reported from Kalaburagi and two have been identified from Mudhol.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.